Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.27B
-
Number of holders
-
1581
-
Total 13F shares, excl. options
-
865M
-
Shares change
-
+19.2M
-
Total reported value, excl. options
-
$68.1B
-
Value change
-
+$1.78B
-
Put/Call ratio
-
0.8
-
Number of buys
-
761
-
Number of sells
-
-732
-
Price
-
$78.72
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q3 2018
1,770 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q3 2018.
CVS HEALTH Corp - Common Stock (CVS) has 1,581 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 865M shares
of 1.27B outstanding shares and own 68.21% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (84.9M shares), BlackRock Inc. (76.2M shares), STATE STREET CORP (41.5M shares), FMR LLC (30.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (21.2M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (19.8M shares), WELLINGTON MANAGEMENT GROUP LLP (18.2M shares), JPMORGAN CHASE & CO (17.7M shares), PARNASSUS INVESTMENTS /CA (16.5M shares), and DODGE & COX (15.1M shares).
This table shows the top 1581 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.